Document is current
Any future updates will be listed below
-
Authors
Baldwin, Jeremy G. https://orcid.org/0000-0002-0367-8939
Heuser-Loy, Christoph https://orcid.org/0000-0003-1410-7573
Gattinoni, Luca https://orcid.org/0000-0003-2239-3282
- License Information
-
More Information
Article History
Accepted: 19 August 2025
First Online: 9 October 2025
Competing interests
: J.G.B. and L.G. have a patent application for the use of mitochondrial transfer technology in cancer immunotherapies. L.G. has consulting agreements with Lyell Immunopharma. L.G. is a scientific advisor and a stockholder of CellRep. C.H.-L. declares no competing interests.
